Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675722 · ClinicalTrials.gov registry record · Phase 1
Implantation Of Vaginal Construct For Patients With Vaginal Aplasia
A Phase 1 study of Congenital Mullerian Duct Anomaly, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05675722 is a Phase 1 study of Congenital Mullerian Duct Anomaly that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05675722, a Phase 1 study of Congenital Mullerian Duct Anomaly, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
In this Phase 1, single site, clinical trial, Vulvar/vaginal Smooth muscle cells (SMC) and Epithelial Cells (EPC) are isolated from autologous patient's biopsy
Conditions Studied
Interventions
- BIOLOGICAL biologic vaginal-construct implantation
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2029-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05675722
The ClinicalTrials.gov registry entry for NCT05675722 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Mullerian Duct Anomaly appearing as the primary indexed condition, and to 1 intervention - of which biologic vaginal-construct implantation is the first listed.
NCT05675722 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05675722 about?
NCT05675722 is a clinical study titled "Implantation Of Vaginal Construct For Patients With Vaginal Aplasia". In this Phase 1, single site, clinical trial, Vulvar/vaginal Smooth muscle cells (SMC) and Epithelial Cells (EPC) are isolated from autologous patient's biopsy
What is the current status of trial NCT05675722?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2023-06-01. Estimated completion is 2029-12.
What conditions does trial NCT05675722 study?
This clinical trial studies the following conditions: Congenital Mullerian Duct Anomaly.
What interventions are being tested in trial NCT05675722?
The interventions under investigation include: biologic vaginal-construct implantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT05675722?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675722 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.